Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 ?20%

Basit Öğe Kaydı
dc.contributor.authorOzaslan, E.
dc.contributor.authorKoca, S.
dc.contributor.authorSevinc, A.
dc.contributor.authorHacioglu, B.
dc.contributor.authorOzcelik, M.
dc.contributor.authorDuran, A. O.
dc.contributor.authorCiltas, A.
dc.date.accessioned2026-08-12T17:25:53Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease -- MAR 09-11, 2016 -- Barcelona, SPAIN
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipENETS
dc.identifier.endpage74
dc.identifier.issn0028-3835
dc.identifier.issn1423-0194
dc.identifier.startpage74
dc.identifier.urihttps://hdl.handle.net/11508/54561
dc.identifier.volume103
dc.identifier.wosWOS:000386481600195
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherKarger
dc.relation.ispartofNeuroendocrinology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectSomatostatin analogue
dc.subjectNET
dc.subjectKi-67
dc.titleComparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 ?20%
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu